INVESTIGATION OF NEUROPROTECTIVE ANTIOXIDANT: EFFECT OF SABINENE IN KETAMINE-INDUCED EXPERIMENTAL SCHIZOPHRENIA IN MICE

Student: Lydia Ben-Azu
Supervisor: Mr Onyeka Benjamin Onyeukwu
HOD: Dr Queen Umudi
Department of Biochemistry
Science
University of Delta, Agbor, Delta State

Abstract

Schizophrenia is a serious neuropsychiatric disorder marked by oxidative stress, immune system changes, and neurochemical imbalances. Current treatments are constrained by inconsistent effectiveness and side effects. This study evaluates the neuroprotective effects of sabinene, a monoterpene, in a ketamine-induced schizophrenia mouse model. Male mice (n=9/group) received ketamine (25 mg/kg/day, i.p.) for 14 days to induce schizophrenia-like deficits, followed by treatment with sabinene (5 or 10 mg/kg, p.o.) or risperidone (0.5 mg/kg, p.o.) from days 8-14. Neurochemical analyses assessed oxidative stress markers, including superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), reduced glutathione (GSH), malondialdehyde (MDA), and nitrite. This was followed by assays of acetylcholinesterase and levels of cytokines (IL-6 and IL-10) in the prefrontal cortex, striatum hippocampus. Ketamine induced hyperactivity, social withdrawal and memory impairment were reversed by sabinene compared to the ketamine group. Sabinene (10 mg/kg) and risperidone restored SOD, GST, GSH, and CAT levels across regions. The increased MDA and nitrite levels by ketamine were reversed by sabinene in the prefrontal cortex, striatum, and hippocampus compared to the ketamine groups. Sabinene (10 mg/kg) also attenuated acetylcholinesterase in the prefrontal cortex and hippocampus (p < 0.0078). The 5 mg/kg dose showed limited efficacy, indicating dose-dependency. Sabinene’s efficacy, comparable to risperidone, involves enhancement of the cholinergic system and inhibition of oxidative/nitrergic stress, suggesting its potential as a therapeutic agent for schizophrenia by improving cholinergic transmission deficits. Further mechanistic and clinical studies are warranted to optimize sabinene’s therapeutic benefits and antipsychotic potential. Ketamine, Oxidative stress, Schizophrenia, Antioxidants, Sabinene, Acetylcholine.

Full-Text Access Notice

In accordance with the NERD Policy on promoting peer-reviewed publication, public access to the full text of a project, thesis or dissertation is restricted for three years, allowing the author and supervisors sufficient time to pursue peer-reviewed publication. During this period, researchers with legitimate academic or research purposes may request authorisation directly from the author to enable NERD to release the indexed full texts of the work using the form below.

Request authorisation from the author